Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2150
Understanding Unmet Needs and Quality of Life Impact of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) Using Social Media: A Patient and Caregiver Perspective
Patient Outcomes, Preferences, & Attitudes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2102
Unraveling Knee Osteoarthritis Subtypes: Differential Effect of Oral Salmon Calcitonin Treatment
Osteoarthritis – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 2333
Unveiling New Molecular Signatures in Psoriatic Arthritis Using Comprehensive Proteomic Analysis of Peripheral Mononuclear Cells
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2244
Unveiling Synovial Protein Contributions to Serum Inflammation, Disease Activity, and Treatment Outcomes in RA Patients
RA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2133
Unveiling the Association Between Low-Density Lipoprotein Cholesterol Lowering and Fracture Risk Among Patients with Hyperlipidaemia in a Population-Based Cohort Study: The Lower, the Better
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 1826
Unveiling the Primary Cilia Signature Driving Systemic Sclerosis Pathogenesis
Systemic Sclerosis & Related Disorders – Basic Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2515
Upadacitinib for Refractory Behçet’s Syndrome: A Multi-center, Prospective, Open-label, Pilot Study
Vasculitis – Non-ANCA-Associated & Related Disorders Poster III- 10:30AM-12:30PM
-
Abstract Number: 2367
Updated Long-Term Safety and Tolerability of Bimekizumab in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: Pooled Results from Phase 2b/3 Studies
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 1995
Use of Abatacept for the Treatment of Severe Immune-related Adverse Events from Immune Checkpoint Inhibitors for Cancer: A Case Series
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 1929
Use of Digital Health Tools for Health Promotion Among Individuals with Rheumatologic Diseases in the United States
Health Services Research – ACR/ARP Poster III- 10:30AM-12:30PM
-
Abstract Number: 1925
Use of Geocoded Social Deprivation Indices to Understand Health Disparities in Pediatric Rheumatology
Healthcare Disparities in Rheumatology Poster III- 10:30AM-12:30PM
-
Abstract Number: 1984
Use of ICD Codes for the Identification of Patients with Immune Checkpoint Inhibitor Induced Inflammatory Arthritis
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 2276
Use of Methotrexate and TNF-α Inhibitors in Patients with Rheumatoid Arthritis-associated Interstitial Lung Disease: A Survey of Rheumatologists
RA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2459
Use of Nailfold Capillaroscopy as a Predictor of Cardiovascular Events and Mortality in Systemic Sclerosis